Active cocaine users with heart failure with reduced ejection fraction (HFrEF) benefited from beta-blocker therapy in a recent study, seeing improved left ventricular ejection fraction (LVEF) and reduced rates of cocaine-related CV events despite long-standing worries that the treatment might exacerbate symptoms of HF.

Abbott on Jan. 21 announced the FDA approval of one of its atrial fibrillation (AFib) ablation catheters, the TactiCath Contact Force Ablation Catheter.

An advisory panel to the FDA voted 8-8 Jan. 17 on a motion to approve the type 1 diabetes drug sotagliflozin, Reuters reported.

Trained “glycemia alert dogs” are more reliable in signaling out-of-range (OOR) blood sugar levels to their owners with type 1 diabetes than previously reported, according to a new study published in PLOS One.

The majority of patients who present to the emergency department (ED) after fainting likely don’t need to be monitored for more than two hours to rule out any dangerous underlying arrhythmias, Canadian researchers have found.

A prospective, single-center study from Denmark suggests nearly half of patients develop a new conduction abnormality after transcatheter aortic valve replacement (TAVR), impacting their short-term and long-term prognosis.

Young victims of sudden cardiac arrest (SCA) and death are more likely to have a history of cardiovascular disease and some relationship with drugs or psychiatric illness, according to research published Jan. 19 in the Journal of the American Heart Association.

Women implanted with cardiac implantable electronic devices (CIEDs) like pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy technologies are more likely to experience acute CIED complications than men who undergo the same procedures, according to work published Jan. 16 in the Journal of the American Heart Association.